Drugs for the treatment of pulmonary arterial hypertension [ID12]

Pulmonary arterial hypertension (adults) - drugs: letter to stakeholders announcing removal of appraisal from the NICE work programme ^{PDF 21 KB} 06 April 2009  

Pulmonary arterial hypertension (adults) - drugs: provisional matrix for consultation on 28 Oct 08 ^{PDF 42 KB} 05 November 2008  

Pulmonary arterial hypertension (adults) - drugs: letter sent to new consultees and commentators on 28 Oct 08 ^{PDF 34 KB} 05 November 2008  

Pulmonary arterial hypertension (adults) - drugs: draft remit and scope to consultees and commentators for consultation 28 Oct 08 ^{PDF 36 KB} 05 November 2008  

Pulmonary arterial hypertension (adults) - drugs: letter sent to existing consultees and commentators on 28 Oct 08 ^{PDF 30 KB} 05 November 2008  

Pulmonary arterial hypertension (adults) - drugs: letter to consultees and commentators regarding delay to the appraisal ^{PDF 23 KB} 21 August 2008  

Pulmonary arterial hypertension (adults) - drugs: evaluation report  

Additional report by the Assessment Group ^{PDF 252 KB} 03 March 2008  

Additional report by the Assessment Group: further analyses ^{PDF 40 KB} 03 March 2008  

Results of the request for additional survival data and incremental results of cost-effectiveness analysis ^{PDF 66 KB} 03 March 2008  

Overview ^{PDF 222 KB} 03 March 2008  

Response to consultee and commentator comments on the Assessment Report from the West Midlands Regional Health Technology Assessment Collaboration ^{PDF 29 KB} 03 March 2008  

Assessment report ^{PDF 1.25 MB} 03 March 2008  

Results of the request for additional survival data and incremental results of cost-effectiveness analysis  

Actelion Pharmaceuticals UK Ltd ^{PDF 12 KB} 03 March 2008  

Bayer Healthcare ^{PDF 12 KB} 03 March 2008  

Encysive Pharmaceuticals UK Ltd ^{PDF 12 KB} 03 March 2008  

NHS Quality Improvement Scotland ^{PDF 13 KB} 03 March 2008  

Royal College of Physicians ^{PDF 13 KB} 03 March 2008  

National Pulmonary Vascular Diseases Unit 2 ^{PDF 13 KB} 03 March 2008  

National Pulmonary Vascular Diseases Unit 1 ^{PDF 13 KB} 03 March 2008  

Consultee and commentator comments on the assessment report  

Actelion Pharmaceuticals UK Ltd ^{PDF 61 KB} 03 March 2008  

Bayer Healthcare ^{PDF 17 KB} 03 March 2008  

British Cardiovascular Society ^{PDF 51 KB} 03 March 2008  

British Society for Rheumatology ^{PDF 141 KB} 03 March 2008  

British Thoracic Society ^{PDF 21 KB} 03 March 2008  

Department of Health ^{PDF 13 KB} 28 February 2008  

Encysive Pharmaceuticals UK Ltd ^{PDF 29 KB} 03 March 2008  

Pulmonary Arterial Hypertension Association UK ^{PDF 676 KB} 03 March 2008  

Royal College of Physicians ^{PDF 44 KB} 03 March 2008  

Royal College of Nursing ^{PDF 15 KB} 03 March 2008  

NHS Quality Improvement Scotland ^{PDF 34 KB} 03 March 2008  

GlaxoSmithKline ^{PDF 76 KB} 03 March 2008  

Non-manufacturer submission  

Joint Submission by The West Midlands Specialised Commissioning Team(WMSCG), South Staffordshire Primary Care Trust, North West London Specialised Commissioning Team (London SCG) ^{PDF 24 KB} 03 February 2008  

Royal College of Physicians and British Cardiovascular Society ^{PDF 412 KB} 03 March 2008  

Royal College of Nursing ^{PDF 15 KB} 03 March 2008  

Raynaud's & Scleroderma Association ^{PDF 35 KB} 03 March 2008  

Pulmonary Arterial Hypertension Association UK ^{PDF 676 KB} 03 March 2008  

British Society for Rheumatology ^{PDF 100 KB} 03 March 2008  

Manufacturer submissions (executive summary only)  

Schering Health Care Ltd ^{PDF 71 KB} 03 March 2008  

Pfizer Ltd ^{PDF 11 KB} 03 March 2008  

GlaxoSmithKline ^{PDF 24 KB} 03 March 2008  

Encysive pharmaceuticals UK Ltd ^{PDF 25 KB} 03 March 2008  

Actelion Pharmaceuticals UK Ltd ^{PDF 49 KB} 03 March 2008  

Expert written personal statements  

Townsley ^{PDF 24 KB} 03 March 2008  

Pannell ^{PDF 21 KB} 03 March 2008  

Gin-Sing ^{PDF 15 KB} 03 March 2008  

Corris ^{PDF 25 KB} 03 March 2008  

Pulmonary arterial hypertension (adults) - drugs: treatment of pulmonary arterial hypertension letter ^{PDF 22 KB} 04 January 2008  

Pulmonary arterial hypertension (adults) - drugs: final protocol ^{PDF 94 KB} 23 February 2007  

Pulmonary arterial hypertension (adults) - drugs: final scope ^{PDF 43 KB} 11 January 2007  

Pulmonary arterial hypertension (adults) - drugs: comments on draft scope ^{PDF 174 KB} 11 January 2007  

Pulmonary arterial hypertension (adults) - drugs: comments on provisional matrix of consultees and commentators ^{PDF 37 KB} 11 January 2007  

Pulmonary arterial hypertension (adults) - drugs: additional analysis ^{PDF 27 KB} 26 October 2007